Dr Amy Rasco Coffey, MD | |
5323 Harry Hines Blvd, Dallas, TX 75390-7208 | |
(214) 645-0624 | |
(214) 645-0078 |
Full Name | Dr Amy Rasco Coffey |
---|---|
Gender | Female |
Speciality | Otolaryngology - Pediatric Otolaryngology |
Location | 5323 Harry Hines Blvd, Dallas, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407947013 | NPI | - | NPPES |
131519404 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207YP0228X | Otolaryngology - Pediatric Otolaryngology | H0715 (Texas) | Primary |
Entity Name | University Of Texas Southwestern Medical Center At Dallas |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
ASUS, a leading developer of notebook PCs, today announced that it has launched two new notebook computer models that incorporate SiBEAM, Inc.'s WirelessHD technology, enabling the most robust wireless display solution available. These notebook PCs are the world's first to feature WirelessHD technology. By integrating SiBEAM's advanced wireless video network chips on display mini-card (DMC) modules, these notebooks will offer an unprecedented wireless experience for consumers and gamers at compelling price points.
A new study shows significant differences in brain development in high-risk infants who develop autism starting as early as age 6 months. The findings published in the American Journal of Psychiatry reveal that this abnormal brain development may be detected before the appearance of autism symptoms in an infant's first year of life. Autism is typically diagnosed around the age of 2 or 3.
For the first time ever, a completely man-made chemical enzyme has been successfully used to neutralise a toxin found naturally in fruits and vegetables. While studying for her PhD in chemistry at the University of Copenhagen Dr. Jeannette Bjerre showed how a novel so called chemzyme was able to decompose glycoside esculin, a toxin found in horse-chestnuts.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Amy Rasco Coffey, MD Po Box 845347, Dallas, TX 75284-5347 Ph: (214) 645-0624 | Dr Amy Rasco Coffey, MD 5323 Harry Hines Blvd, Dallas, TX 75390-7208 Ph: (214) 645-0624 |
News Archive
ASUS, a leading developer of notebook PCs, today announced that it has launched two new notebook computer models that incorporate SiBEAM, Inc.'s WirelessHD technology, enabling the most robust wireless display solution available. These notebook PCs are the world's first to feature WirelessHD technology. By integrating SiBEAM's advanced wireless video network chips on display mini-card (DMC) modules, these notebooks will offer an unprecedented wireless experience for consumers and gamers at compelling price points.
A new study shows significant differences in brain development in high-risk infants who develop autism starting as early as age 6 months. The findings published in the American Journal of Psychiatry reveal that this abnormal brain development may be detected before the appearance of autism symptoms in an infant's first year of life. Autism is typically diagnosed around the age of 2 or 3.
For the first time ever, a completely man-made chemical enzyme has been successfully used to neutralise a toxin found naturally in fruits and vegetables. While studying for her PhD in chemistry at the University of Copenhagen Dr. Jeannette Bjerre showed how a novel so called chemzyme was able to decompose glycoside esculin, a toxin found in horse-chestnuts.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older.
› Verified 7 days ago
Dr. Anthony Michael Tolisano, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3102 | |
Presley M. Mock, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8440 Walnut Hill Ln, Ste 500, Dallas, TX 75231 Phone: 214-345-1491 Fax: 214-345-5708 | |
Dr. Jane Farrar Admire, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7777 Forest Ln, Suite C-100, Dallas, TX 75230 Phone: 972-566-4848 | |
Chung-en Huang, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3430 W Wheatland Rd Ste 209, Dallas, TX 75237 Phone: 972-780-1496 Fax: 972-709-1496 | |
Dr. Seckin Omer Ulualp, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1935 Medical District Dr, Dallas, TX 75235 Phone: 214-456-2905 | |
Dr. Kenneth H Lee, M.D., PH.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd., Ut Soutwestern Otolaryngology, Dallas, TX 45229 Phone: 214-648-2972 Fax: 214-648-9122 | |
Jacob Boston Hunter, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-8898 Fax: 214-645-8894 |